1. Home
  2. QRHC vs NRSN Comparison

QRHC vs NRSN Comparison

Compare QRHC & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quest Resource Holding Corporation

QRHC

Quest Resource Holding Corporation

HOLD

Current Price

$0.93

Market Cap

33.4M

Sector

Utilities

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.82

Market Cap

28.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QRHC
NRSN
Founded
N/A
2017
Country
United States
Israel
Employees
N/A
15
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.4M
28.4M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
QRHC
NRSN
Price
$0.93
$0.82
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
32.7K
167.6K
Earning Date
06-19-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$138,346,327.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$0.68
52 Week High
$3.12
$2.60

Technical Indicators

Market Signals
Indicator
QRHC
NRSN
Relative Strength Index (RSI) 17.99 40.95
Support Level N/A $0.68
Resistance Level $2.30 $1.30
Average True Range (ATR) 0.17 0.07
MACD -0.07 -0.00
Stochastic Oscillator 3.47 19.62

Price Performance

Historical Comparison
QRHC
NRSN

About QRHC Quest Resource Holding Corporation

Quest Resource Holding Corp is a national provider of waste and recycling services to customers from across multiple industry sectors that are typically larger, multi-location businesses. The company creates customer-specific programs and perform the related services for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. The company's services focus on the waste streams and recyclables from box, grocers, and other specialty retailers; automotive after-market operations such as automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and fleet operators; manufacturing and industrial facilities; multi-family and commercial properties; restaurant chains and food operations, etc.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: